Chemours Co (CC) stock
CCNYSEChemicals & Allied ProductsFiscal year ends December 31
$12.18−0.30 (-2.40%)
Close on Nov 17, 2026Market cap $1.83BP/E –Yield 4.21%
Chemours revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Chemours's revenue for the twelve months ending Jun 30, 2026 was $5.80B, down 0.9% year over year. For fiscal 2025 it was $5.81B, up 0.4% from the year before. Over ten years it grew 0.2% a year on average. The highest annual figure on record is $6.86B in fiscal 2013.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.81B | +0.4% |
| FY2024 | Dec 31, 2024 | $5.78B | -4.9% |
| FY2023 | Dec 31, 2023 | $6.08B | -11.0% |
| FY2022 | Dec 31, 2022 | $6.83B | +7.7% |
| FY2021 | Dec 31, 2021 | $6.35B | +27.7% |
| FY2020 | Dec 31, 2020 | $4.97B | -10.1% |
| FY2019 | Dec 31, 2019 | $5.53B | -16.8% |
| FY2018 | Dec 31, 2018 | $6.64B | +7.4% |
| FY2017 | Dec 31, 2017 | $6.18B | +14.5% |
| FY2016 | Dec 31, 2016 | $5.40B | -5.5% |
| FY2015 | Dec 31, 2015 | $5.72B | -11.1% |
| FY2014 | Dec 31, 2014 | $6.43B | -6.2% |
| FY2013 | Dec 31, 2013 | $6.86B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.59B | -1.5% |
| Q1 FY2026 | Mar 31, 2026 | $1.38B | +1.0% |
| Q4 FY2025 | Dec 31, 2025 | $1.33B | -2.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.50B | -0.9% |
| Q2 FY2025 | Jun 30, 2025 | $1.62B | +3.9% |
| Q1 FY2025 | Mar 31, 2025 | $1.37B | +0.4% |
| Q4 FY2024 | Dec 31, 2024 | $1.36B | -0.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.51B | +0.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.55B | -6.4% |
| Q1 FY2024 | Mar 31, 2024 | $1.36B | -12.1% |
| Q4 FY2023 | Dec 31, 2023 | $1.37B | +2.2% |
| Q3 FY2023 | Sep 30, 2023 | $1.50B | -15.5% |
| Q2 FY2023 | Jun 30, 2023 | $1.66B | -13.3% |
| Q1 FY2023 | Mar 31, 2023 | $1.55B | -12.2% |
| Q4 FY2022 | Dec 31, 2022 | $1.34B | -15.0% |
| Q3 FY2022 | Sep 30, 2022 | $1.78B | +5.8% |
| Q2 FY2022 | Jun 30, 2022 | $1.92B | +15.7% |
| Q1 FY2022 | Mar 31, 2022 | $1.76B | +22.8% |
| Q4 FY2021 | Dec 31, 2021 | $1.58B | +17.7% |
| Q3 FY2021 | Sep 30, 2021 | $1.68B | +36.3% |
| Q2 FY2021 | Jun 30, 2021 | $1.66B | +51.4% |
| Q1 FY2021 | Mar 31, 2021 | $1.44B | +10.0% |
| Q4 FY2020 | Dec 31, 2020 | $1.34B | -1.1% |
| Q3 FY2020 | Sep 30, 2020 | $1.23B | -11.3% |
| Q2 FY2020 | Jun 30, 2020 | $1.09B | -22.4% |
| Q1 FY2020 | Mar 31, 2020 | $1.31B | -5.2% |
| Q4 FY2019 | Dec 31, 2019 | $1.35B | -7.6% |
| Q3 FY2019 | Sep 30, 2019 | $1.39B | -14.6% |
| Q2 FY2019 | Jun 30, 2019 | $1.41B | -22.5% |
| Q1 FY2019 | Mar 31, 2019 | $1.38B | -20.5% |
| Q4 FY2018 | Dec 31, 2018 | $1.46B | -7.0% |
| Q3 FY2018 | Sep 30, 2018 | $1.63B | +2.8% |
| Q2 FY2018 | Jun 30, 2018 | $1.82B | +14.4% |
| Q1 FY2018 | Mar 31, 2018 | $1.73B | +20.4% |
| Q4 FY2017 | Dec 31, 2017 | $1.58B | +19.1% |
| Q3 FY2017 | Sep 30, 2017 | $1.58B | +13.3% |
| Q2 FY2017 | Jun 30, 2017 | $1.59B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.44B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.32B | – |
| Q3 FY2016 | Sep 30, 2016 | $1.40B | – |
See a number that looks wrong?